Fisher & Paykel Healthcare Corporation (ASX:FPH) has provided revenue guidance for the financial year ending 31 March 2023, expecting full year operating revenue within the range of approximately $1.55 billion to $1.60 billion.
Managing Director and Chief Executive Officer Lewis Gradon says sales of the company's hospital hardware and consumables have increased due to COVID-19 surges in China, as well as the prevalence of respiratory syncytial virus in North America, both of which have created short-term impacts on the company's gross margin.
The company also does not expect any material impact on their operating expense growth target.
Fisher & Paykel Healthcare Corporation's share price is up 6% this morning.